Summary of Significant Accounting Policies - Net Loss Per Common Share (Details) - shares |
12 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Warrants | ||
| Net Loss Per Common Share | ||
| Antidilutive securities excluded from diluted net loss per common share computations | 1,500,000 | 700,000 |
| Restricted stock units and Performance restricted stock units | ||
| Net Loss Per Common Share | ||
| Outstanding restricted stock units (in shares) | 330,830 | 221,778 |
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|